A multiplex platform for the identification of ovarian cancer biomarkers

A multiplex platform for the identification of ovarian cancer biomarkers

Abstract Background Currently, there are no FDA approved screening tools for detecting early stage ovarian cancer in the general population. Development of a biomarker-based assay for early detection would significantly improve the survival of ovarian cancer patients. Methods We used a multiplex app...

Full description

Bibliographic Details
Main Authors: Kristin L. M. Boylan, Kate Geschwind, Joseph S. Koopmeiners, Melissa A. Geller, Timothy K. Starr, Amy P. N. Skubitz
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Clinical Proteomics
Subjects:
Ovarian cancer
Biomarkers
Multiplex
CA125
HE4
Proseek®
Online Access:http://link.springer.com/article/10.1186/s12014-017-9169-6

Internet

http://link.springer.com/article/10.1186/s12014-017-9169-6

Similar Items